UPDF AI

Therapeutic Potential of 5-HT2C Receptor Agonists for Addictive Disorders.

G. Higgins,P. Fletcher

2015 · DOI: 10.1021/acschemneuro.5b00025
ACS Chemical Neuroscience · 75 Zitierungen

TLDR

Evidence to support the use of selective 5-HT2C receptor agonists as treatments for conditions beyond obesity, including substance abuse, obsessive compulsive, and excessive gambling disorder is examined.